LUCD
LUCD 49 articles

Lucid Diagnostics: Positioned For A Medicare-Driven Inflection

seekingalpha.com·3d ago

Lucid Diagnostics Inc. (LUCD) Shareholder/Analyst Call Prepared Remarks Transcript

seekingalpha.com·Jun 24

PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results

prnewswire.com·May 15

Lucid Diagnostics Inc. (LUCD) Q1 2026 Earnings Call Transcript

seekingalpha.com·May 14

Lucid Diagnostics Q1 Earnings Call Highlights

marketbeat.com·May 14

Lucid Diagnostics Inc. (LUCD) Reports Q1 Loss, Misses Revenue Estimates

zacks.com·May 14

Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results

prnewswire.com·May 14

Lucid Diagnostics Inc. (LUCD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

zacks.com·May 8

PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026

prnewswire.com·May 1

Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026

prnewswire.com·Apr 30

Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock

prnewswire.com·Apr 24

Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock

prnewswire.com·Apr 23

Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives Average Recommendation of “Moderate Buy” from Analysts

defenseworld.net·Apr 18

Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference

prnewswire.com·Apr 9

PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio

prnewswire.com·Apr 2

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

prnewswire.com·Mar 30

Lucid Diagnostics Q4 Earnings Call Highlights

defenseworld.net·Mar 28

Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives $3.94 Consensus PT from Brokerages

defenseworld.net·Mar 27

Lucid Diagnostics Inc. (LUCD) Q4 2025 Earnings Call Transcript

seekingalpha.com·Mar 26

Lucid Diagnostics Inc. (LUCD) Reports Q4 Loss, Beats Revenue Estimates

zacks.com·Mar 26

Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

prnewswire.com·Mar 26

PAVmed to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 30, 2026

prnewswire.com·Mar 16

Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026

prnewswire.com·Mar 12

Lucid Diagnostics (NASDAQ:LUCD) & Alpha Tau Medical (NASDAQ:DRTS) Financial Survey

defenseworld.net·Feb 20

Inogen (INGN) Soars 6.6%: Is Further Upside Left in the Stock?

zacks.com·Feb 12

PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities

prnewswire.com·Feb 4

Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard®

prnewswire.com·Jan 21

Contrasting Lucid Diagnostics (NASDAQ:LUCD) & Waters (NYSE:WAT)

defenseworld.net·Jan 10

Reviewing Intuitive Surgical (NASDAQ:ISRG) and Lucid Diagnostics (NASDAQ:LUCD)

defenseworld.net·Jan 2

Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection

prnewswire.com·Dec 9

Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree

prnewswire.com·Nov 20

Lucid Diagnostics Inc. (NASDAQ:LUCD) Given Average Recommendation of “Moderate Buy” by Brokerages

defenseworld.net·Nov 19

Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

prnewswire.com·Nov 13

PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results

prnewswire.com·Nov 13

Lucid Diagnostics Inc. (LUCD) Q3 2025 Earnings Call Transcript

seekingalpha.com·Nov 12

Lucid Diagnostics Inc. (LUCD) Reports Q3 Loss, Lags Revenue Estimates

zacks.com·Nov 12

Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results

prnewswire.com·Nov 12

PAVmed to Hold a Business Update Conference Call and Webcast on November 13, 2025

prnewswire.com·Oct 30

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025

prnewswire.com·Oct 29

What Makes Lucid Diagnostics Inc. (LUCD) a Strong Momentum Stock: Buy Now?

zacks.com·Oct 16

Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit

prnewswire.com·Oct 15

Lucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of Directors

prnewswire.com·Sep 25

Lucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government Affairs

prnewswire.com·Sep 16

Lucid Diagnostics Announces Closing of Public Offering of Common Stock

prnewswire.com·Sep 11

Lucid Diagnostics Announces Pricing of Public Offering of Common Stock

prnewswire.com·Sep 10

Lucid Diagnostics Announces Proposed Public Offering of Common Stock

prnewswire.com·Sep 9

Lucid Diagnostics Inc. (LUCD) Investor Conference Call (Transcript)

seekingalpha.com·Sep 8

Lucid Diagnostics to Host Investor Call on Monday, September 8, 2025

prnewswire.com·Sep 5

PAVmed Signs Letter of Intent to License Groundbreaking Endoscopic Esophageal Imaging Technology

prnewswire.com·Aug 26
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.